Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Allotransplantation Stories

2014-01-16 16:24:21

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ql5c3g/orthobiologics) has announced the addition of the "Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/ql5c3g/orthobiologics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Orthobiology is a branch of science that...

2014-01-16 12:29:30

LONDON, Jan. 16, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: UK Orthopedic Biomaterial Market Forecast To 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in the UK through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth Stimulators--...

2014-01-14 16:25:25

LONDON, Jan. 14, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: US Orthopedic Biomaterial Market Outlook and Trends Till 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in the US through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth...

2014-01-13 12:28:13

LONDON, Jan. 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: India Orthopedic Biomaterial Market Forecast To 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in India through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth Stimulators--...

2014-01-13 12:28:11

LONDON, Jan. 13, 2014 /PRNewswire/ -- UK-ReportbuyerReportbuyer.com just published a new market research report: China Orthopedic Biomaterial Market Forecast To 2018 Short DescriptionThis research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in China through 2018.The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth...

2014-01-08 12:28:58

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:US Orthopedic Devices Market Assessment and Forecast To 2018Short DescriptionThe Market Intelligence report provides critical market data for US orthopedic devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.It's vital...

2014-01-07 08:31:33

First NiTiNOL-based large joint fusion device reaches 100 implantations in limited launch ATLANTA, Jan. 7, 2014 /PRNewswire/ -- MedShape, Inc., the industry leader in innovative shape memory orthopedic devices, today reported on the first wave of clinical outcomes in patients who have received the DynaNail(®) TTC Fusion System. To date during its targeted soft launch period, DynaNail has been successfully implanted in over 100 tibiotalocalcaneal (TTC) fusion procedures. Because the...

2013-12-30 23:04:26

Navy Corpsman Joins 29 Organ and Tissue Transplant Recipients as Float Riders to Demonstrate Appreciation of Life-Saving Donor Gifts Alachua, FL (PRWEB) December 30, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced that Navy Corpsman Edward Bonfiglio, a patient who received limb sparing surgery utilizing AxoGen’s...

2013-12-30 04:20:18

HORSHOLM, Denmark, Dec. 30, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus(®) (formerly LCP-Tacro(TM)) for the prevention of organ rejection in kidney transplant recipients. The submission is based on the entire data set from the company's clinical development program that comprised 25 studies and...

2013-12-24 08:23:55

HORSHOLM, Denmark, Dec. 24, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus(® )was granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prophylaxis of organ rejection in patients receiving allogenic kidney transplants. The designation is to encourage the development of drugs that may provide significant benefit to patients suffering from rare diseases. Envarsus(®) is Veloxis' once-daily formulation of tacrolimus...